STOCK TITAN

KOD (NASDAQ: KOD) scheduled sale of 30,000 shares after option exercise

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

KOD filed a Rule 144 notice reporting proposed sales of 30,000 shares. The form states the securities are Common stock and lists an Exercise of Stock Options with an intended sale of 30,000 shares on 06/04/2026 for cash. The filing also notes a prior 10b5-1 sale by John Borgeson on 04/02/2026 of 30,000 shares for $1,197,453.00.

Positive

  • None.

Negative

  • None.

Insights

Rule 144 notice documents planned resale of exercised shares and an earlier 10b5-1 sale.

The filing lists an exercise of stock options that produced 30,000 shares and an intended sale of those shares on 06/04/2026. It separately records a prior 10b5-1 sale by John Borgeson on 04/02/2026 of 30,000 shares for $1,197,453.00.

These entries are routine compliance disclosures documenting timing and size of transactions. Cash‑flow treatment for the planned sale is stated as cash; further trade execution details are not included in the excerpt.

Planned sale 30,000 shares Intended sale on 06/04/2026 from option exercise
Prior 10b5-1 sale 30,000 shares Sale executed 04/02/2026 by John Borgeson
Proceeds reported for prior sale $1,197,453.00 Consideration received on 04/02/2026 10b5-1 sale
10b5-1 regulatory
"10b5-1 Sales for JOHN BORGESON 1250 Page Mill Road"
A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.
Exercise of Stock Options financial
"Exercise of Stock Options | Issuer | 30000 | 06/04/2026"
Rule 144 regulatory
"Filer Information | 144: Filer Information"
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does KOD's Form 144 report?

The form reports a planned sale of 30,000 shares of Common stock tied to an exercise of stock options with an intended sale date of 06/04/2026. It also lists a prior 10b5-1 sale by John Borgeson.

Who executed the prior 10b5-1 sale listed on the filing?

The prior 10b5-1 sale was executed by John Borgeson on 04/02/2026, disposing of 30,000 shares for $1,197,453.00, as stated in the excerpt.

How many shares are listed as to be sold on 06/04/2026?

The excerpt lists an intended sale of 30,000 shares on 06/04/2026 resulting from an exercise of stock options, with settlement described as cash in the filing.

Does the filing state how proceeds will be used?

The filing identifies the transaction method as cash but does not specify any use of proceeds or recipient designation in the provided excerpt.

Is the 10b5-1 sale amount disclosed in the excerpt?

Yes. The excerpt shows a 10b5-1 sale on 04/02/2026 of 30,000 shares for $1,197,453.00, which appears as a historical sale recorded on the form.